Skip to content

DocGo DCGO Indefinite- lived intangible impairment

Indefinite- lived intangible impairment at other companies

InfuSystem Holdings logo
InfuSystem HoldingsINFU
Nutex Health Inc. logo
Nutex Health Inc.NUTX
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's indefinite- lived intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's indefinite- lived intangible impairment?
DocGo (DCGO) reported indefinite- lived intangible impairment of $0 in Q1 2026.
How has DocGo's indefinite- lived intangible impairment changed year-over-year?
DocGo's indefinite- lived intangible impairment decreased by 100.0% year-over-year, from $43.84M to $0.
What is the long-term trend for DocGo's indefinite- lived intangible impairment?
Over 3 years (2022 to 2025), DocGo's indefinite- lived intangible impairment has grown at a 43.8% compound annual growth rate (CAGR), from $14.73M to $43.84M.